SCHEMBL6257579

SCHEMBL6257579

Cn1c(=O)n(Cc2ccccc2)c(=O)c2c(C(=O)OCC3CCC3)csc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.41
DRD4 P21917 3/20 0.41
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
CHRNB4 P30926 5/20 0.40
CHRNA3 P32297 5/20 0.40
CHRNB2 P17787 3/20 0.40
CHRNA4 P43681 3/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101392 0.97 CHRM2 (0.41) DRD2DRD4MEN1KMT2ALMNA
SCHEMBL7017390 0.96 DRD2 (0.42) DRD2DRD4MEN1KMT2ALMNA
SCHEMBL6473589 0.87 CYP1A2 (0.46) LMNAMAPTKDM4EHPGDALDH1A1
SCHEMBL6471284 0.85 MEN1 (0.46) MEN1KMT2ALMNAMAPTKDM4E
SCHEMBL6474542 0.83 ADORA2B (0.44) MEN1KMT2AHPGDALDH1A1CYP3A4
SCHEMBL6259138 0.83 SRC (0.48) MEN1KMT2ALMNAKDM4EHPGD
SCHEMBL6472164 0.82 ERCC5 (0.43) MEN1KMT2ALMNAMAPTKDM4E
SCHEMBL6476633 0.82 ALDH1A1 (0.43) MEN1KMT2ALMNAMAPTKDM4E
SCHEMBL6470623 0.82 ADORA2B (0.42) MEN1KMT2ALMNAERCC5FEN1
SCHEMBL6473393 0.82 TSHR (0.47) MEN1KMT2ALMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
EP-1530467-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
WO-2004006912-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed